Drug
Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005%
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Ocular Hyperaemia | 144 | 69.0 | 81.4 | signal |
| 2 | Intraocular Pressure Increased | 34 | 59.3 | 61.5 | signal |
| 3 | Lacrimation Increased | 75 | 56.2 | 61.0 | signal |
| 4 | Ocular Discomfort | 24 | 49.5 | 50.7 | signal |
| 5 | Eye Irritation | 109 | 43.7 | 49.4 | signal |
| 6 | Eye Pruritus | 62 | 42.1 | 45.0 | signal |
| 7 | Product Packaging Quantity Issue | 20 | 41.0 | 41.9 | signal |
| 8 | Eye Discharge | 16 | 35.0 | 35.6 | signal |
| 9 | Eye Pain | 79 | 32.0 | 34.8 | signal |
| 10 | Eye Haemorrhage | 13 | 21.7 | 22.0 | signal |
| 11 | Photophobia | 18 | 21.5 | 21.9 | signal |
| 12 | Eye Inflammation | 9 | 21.3 | 21.5 | signal |
| 13 | Glaucoma | 16 | 18.6 | 18.9 | signal |
| 14 | Vitreous Floaters | 8 | 18.4 | 18.5 | signal |
| 15 | Vision Blurred | 99 | 16.2 | 18.0 | signal |
| 16 | Eye Infection | 7 | 13.9 | 14.0 | signal |
| 17 | Dry Eye | 29 | 13.4 | 13.8 | signal |
| 18 | Visual Acuity Reduced | 19 | 12.7 | 12.9 | signal |
| 19 | Conjunctivitis | 10 | 12.2 | 12.3 | signal |
| 20 | Eye Swelling | 19 | 11.5 | 11.7 | signal |
| 21 | Eyelid Oedema | 6 | 11.5 | 11.5 | signal |
| 22 | Blindness Unilateral | 7 | 11.1 | 11.2 | signal |
| 23 | Uveitis | 5 | 8.3 | 8.3 | signal |
| 24 | Product Storage Error | 12 | 3.1 | 3.1 | signal |